Patents by Inventor Kevin M. Gardinier

Kevin M. Gardinier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Retinoid X receptor modulators
    Patent number: 7348359
    Abstract: The present invention is directed to compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof: (I). The invention is also directed to pharmaceutical compositions, methods of use and methods of making compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: March 25, 2008
    Assignees: Eli Lilly and Company, Ligand Pharmaceuticals
    Inventors: Kevin M. Gardinier, Douglas L. Gernert, Timothy A. Grese, David A. Neel, Christopher M. Mapes, Pierre-Yves Michellys, Marcus F. Boehm
  • (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
    Publication number: 20040248913
    Abstract: The present invention relates to a method of modulating retinoid X receptor activity in a mammal, novel compounds and pharmaceutical compositions for
    Type: Application
    Filed: May 26, 2004
    Publication date: December 9, 2004
    Inventors: Timothy Alan Grese, Kevin M Gardinier, Marcus F Boehm
  • Retinoid x receptor modulators
    Publication number: 20040167160
    Abstract: The present invention is directed to compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof: (I). The invention is also directed to pharmaceutical compositions, methods of use and methods of making compounds represented by Structural Formula (I) and pharmaceutically acceptable salts, solvates and hydrates thereof.
    Type: Application
    Filed: January 16, 2004
    Publication date: August 26, 2004
    Inventors: Kevin M. Gardinier, Douglas J. Gernert, Timothy A. Grese, David A. Neel, Christopher M. Mapes, Pierre-Yves Michellys, Marcus F. Boehm